Training

Preconference and Postconference Training will be offered in conjunction with the 2008 Conference. Click here to Register!

 

Monday, 21 April 2008

Each session is 8:00 am - 5:00 pm (Lunch break 12:00 - 1:00 pm).



Basic Training: Good Laboratory Practice

Session Chair: Kimberly S. Frazier, Pfizer, Inc.

Speakers:
James J. Carignan, Vital Bridge, Inc.
Kimberly S. Frazier, Pfizer, Inc.
Sherry L. Garrett, Pfizer Animal Health

Target Audience:
This course is directed towards new GLP auditors, study directors, monitors, coordinators, scientists, technical staff, supervisors and management involved with GLP studies. The course could also serve as a refresher for more experienced GLP auditors and study personnel.

Course Objectives:
The attendee will gain an understanding of the history behind the development of the Good Laboratory Practice regulations. The attendee will gain a basic understanding of the principles of the Good Laboratory Practice regulations.
The attendee will gain an understanding of the effects of non-compliance with the Good Laboratory Practice regulations.

Course Description:
This full day basic training course offers a comprehensive and practical approach to the Good Laboratory Practice (GLP) FDA and EPA (FIFRA and TSCA) regulations and standards. The course includes examples and an exercise in the application of the regulations. The course is designed for individuals associated with toxicology, metabolism, residue, product chemistry and other studies conducted under the GLPs and will be presented by knowledgeable speakers.

 

Advanced Training: Good Laboratory Practice

Session Chair: Jeanne deWard RQAP-GLP, Charles River Laboratories

Speakers:
James J. Carignan, Vital Bridge, Inc.
Jeanne deWard RQAP-GLP, Charles River Laboratories
Gregory Furrow, Charles River Laboratories
Guy H. Gardner RQAP-GLP, GlaxoSmithKline
James F. McCormack PhD, Charles River Laboratories Preclinical Services

Target Audience:
Quality Assurance professionals with two or more years of auditing experience in the GLP environment

Course Objectives:

  1. Build on knowledge of the GLP regulations to enhance auditing and inspecting skills
  2. Learn how to make audit reports more effective.
  3. Learn how to maximize the positive effects of FDA inspections

Course Description:
You know the GLPs and you have learned how to audit. What is the next level on the learning curve? This one-day session is devoted to interpreting the ‘short and simple’ GLPs in an increasingly complex environment, and becoming more effective in your role as the “Voice of GLP” in your workplace. The session will focus on different approaches for auditing data and final reports, “hot” or controversial topics in auditing, and tips for writing effective audit reports. We will explore approaches for managing FDA and EPA GLP inspections and ways to foster good relationships among sponsors, contractors and subcontractors. This session is intended for QA professionals with 2 years or more GLP experience.

 


Advanced Concepts in Computer Validation

Session Chair: Joseph A. Franchetti, JAF Consulting, Inc.

Speakers: TBA

This full-day training session is designed to take the QA Professional to the next level of understanding validation challenges. This course is designed for individuals who already possess an understanding of basic validation concepts and are ready to move on to new topics and issues. The first half of the day, we will focus on the practical application of regulations in the laboratory setting and challenges of maintaining systems and archiving data.

The second half of the day will focus on vendor audits. During this session, we will present practical guidance from the point of determining whether you need to conduct a vendor audit, setting up the site visit, and knowing which documents to request for review (what's reasonable and what type of documentation is likely to be available). The break-out sessions will focus on a mock exercise and review of vendor data and allow you to apply the techniques learned.

Course topics will provide attendees with information on:
• Maintaining the validated state;
• Retirement and decommissioning of computer systems;
• Electronic archiving;
• Laboratory systems – qualification vs. validation; and
• Vendor audit.


Current Topics in Good Clinical Practice

Session Chairs: Eileen Donovan RN, Cephalon, Inc.
John Coundouris, Tercica, Inc.

Speakers:
Carl Anderson, Biologics Consulting Group, Inc.
Pamela K. Barry, Cephalon, Inc.
Antonio Bumarch Jr., Cephalon, Inc.
Eileen Donovan RN, Cephalon, Inc.
Jacqueline M. Hevy RQAP-GCP, Amgen, Inc.
Jean Toth-Allen PhD, FDA/OC/OSHC/GCPP
Michael A. Trapani, The Biologics Consulting Group
Lee Truax-Bellows RQAP-GCP, Norwich Clinical Research Associates, Ltd.

Target Audience:
GCP Auditors with 2 or more years experience that are willing to participate in interactive sessions.

Course Objectives:

  1. The attendee shall be able to distinguish between Fraud and Misconduct
  2. The attendee shall gain experience in FDA Inspections of a Sponsor
  3. The attendee will learn about the changes in the EMEA Directives

Course Description:
This interactive session will cover a variety of current GCP topics. Topics will include an interactive session on Fraud and Misconduct, Preparing for an FDA Sponsor audit, Auditing Around the World and Lessons learned when discontinuing a study Investigator for non-compliance. Participants will be encouraged to share experiences and new ideas with the attendees, with a goal of enhancing current GCP knowledge and developing new approaches to auditing. Active participation of the attendees will be a key ingredient to the success of this course. The course will be facilitated by auditors with significant experience and expertise in their area of discussion.

 


BioAnalytical Training

Session Chairs: Maria T. Radino, HLS
Angie L. Harris, HLS

Speakers:
Irina B. Colligon
Anthony B. Jones, Taylor Technology, Inc.
Janet L. Emeigh MS, GlaxoSmithKline
Helen H. Lysy RQAP-GLP, PPD, Inc.
Victoria A. Spendel PhD, PAREXEL Consulting

Target Audience:
GLP auditors at all levels of expertise will benefit from this training session.

Course Objectives:

The attendee will gain a better understanding of various bioanalytical principles and guidance on how to audit laboratories as well as bioanalytical validation and sample analysis study components.

Course Description:
The Bioanalytical Specialty Section will be presenting a full day of training covering a variety of interesting topics for QA auditors at all levels of expertise. Agenda topics will include: Conducting GLP Compliance Audits of Bioanalytical Laboratories, Science and Quality Assurance: PK/QA, Understanding Linear Regressions, Instrument Validation/Qualification Documentation Requirements, ELISAs and Auditing Them, and Improving Efficiency and Effectiveness of Bioanalytical Auditing. Whether you are an expert or a novice, we encourage you to join us.

 

 

Study Director Training

Session Chair: Celeste A. Rose RQAP-GLP, RoseTECH Consulting

Speaker: Celeste A. Rose RQAP-GLP, RoseTECH Consulting

Target Audience:
This workshop is designed for:

  • Study Directors and Principal Investigators
  • Study Personnel who may become Study Directors or Principal investigators
  • Managers or QA professionals, who wish to gain an increased understanding of the Study Director role and GLP responsibilities

Course Objectives:

  1. Gain a greater understanding of GLP regulations that apply to their roles and responsibilities
  2. Locate citations pertaining to specific GLP requirements
  3. Learn how to effectively and compliantly execute quality GLP studies
  4. Generate compliant study protocols, study file documentation, reports
  5. Apply newly learned skills and knowledge to problem solving, mitigation, and prevention

Course Description:
This workshop is designed to provide the participant with a thorough understanding of the GLP requirements and responsibilities of the Study Director role, as well as soft skills and writing skills which are key for effective quality study conduct. The session will cover study compliance and the importance of good documentation, effective writing, and study reconstructability.


Click here for the preliminary meeting schedule

 

 

 
Useful Links